Zevra Therapeutics (ZVRA) Inventory (2024 - 2026)

Zevra Therapeutics (ZVRA) has 3 years of Inventory data on file, last reported at $2.3 million in Q1 2026.

• Quarterly Inventory fell 9.73% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 9.73% YoY) and the FY2025 annual result came in at $1.7 million, down 11.68% from the prior year.
• Inventory improved to $2.3 million in Q1 2026, from $1.7 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $2.6 million in Q1 2025 to a low of $1.1 million in Q2 2025.
• A 3-year average of $1.8 million and a median of $1.9 million in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2025 — Inventory retreated 11.68% — and 2026, when it slipped 9.73%.
• Tracing ZVRA's Inventory over 3 years: stood at $2.0 million in 2024, then retreated by 11.68% to $1.7 million in 2025, then surged by 32.76% to $2.3 million in 2026.
• The last three Inventory figures came in at $2.3 million (Q1 2026), $1.7 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.